BlinkLab Responds to ASX Price and Volume Query
Key points
- No undisclosed information that could explain recent trading
- Results on ADHD diagnostic accuracy not yet available
- Confirming compliance with Listing Rules
Full summary
BlinkLab Limited (ASX: BB1) has responded to an ASX query regarding recent price and volume changes in its securities. The company stated that it is not aware of any information concerning it that has not been announced to the market and which could explain the recent trading in its securities. BlinkLab confirmed that it is complying with the Listing Rules, particularly Listing Rule 3.1. The company noted that the results on ADHD diagnostic accuracy, which were expected to be available in Q2 2025, are not yet available, and it will provide an update when this information is available. BlinkLab's responses to the ASX's questions have been authorized and approved under its published continuous disclosure policy.
Summary generated by a large language model. Please interpret with care.